Le Lézard
Classified in: Health, Business
Subject: TNM

AbbVie Inc. - Form 8.1 - Statement of Stock Purchase by Director


NORTH CHICAGO, Ill., March 30, 2020 /PRNewswire/ -- AbbVie issued the following form today.

IRISH TAKEOVER PANEL

DISCLOSURE UNDER RULE 8.1(a) AND (b)(i) OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013

DEALINGS BY OFFERORS, OFFEREES OR PARTIES ACTING IN CONCERT WITH THEM FOR THEMSELVES OR FOR DISCRETIONARY CLIENTS

1. KEY INFORMATION


Name of person dealing (Note 1)

Richard Gonzalez

Company dealt in

AbbVie Inc.

Class of relevant security to which the dealings being disclosed relate (Note 2)

Common shares, par value $0.01 per share

Date of dealing

25 March 2020

 

2. INTERESTS AND SHORT POSITIONS
(a)Interests and short positions (following dealing) in the class of relevant security dealt in
(Note 3)


Long

Short


Number


(%)

Number


(%)

(1) Relevant securities

377,893 Common Shares (0.00025%)


(2) Derivatives (other than options)

N/A


(3) Options and agreements to purchase/sell

1,161,286 options (0.0008%)


Total

1,539,178 (0.00104%)









(b) Interests and short positions in relevant securities of the company, other than the class dealt in (Note 3) N/A

Class of relevant security:

Long

Short


Number


(%)

Number


(%)

(1) Relevant securities



  (2) Derivatives (other than options)



  (3) Options and agreements to purchase/sell



Total










 

3. DEALINGS (Note 4)
(a) Purchases and sales

Purchase/sale

Number of relevant securities

Price per unit (Note 5)

Withholding of common shares to satisfy tax obligations

56,950 common shares

$0

 

(b) Derivatives transactions (other than options transactions)

Product name,
e.g. CFD

Nature of transaction
(Note 6)

Number of relevant securities
(Note 7)

Price per unit
(Note 5)





 

(c) Options transactions in respect of existing relevant securities
(i) Writing, selling, purchasing or varying

Product name,
e.g. call option

Writing, selling, 
purchasing, 
varying etc.

Number of securities 
to which the option 
relates (Note 7)

Exercise 
price

Type, e.g. 
American, 
European etc.

Expiry 
date

Option money 
paid/received 
per unit (Note 5)








 

(ii) Exercising

Product name,
e.g. call option

Number of securities

Exercise price per unit (Note 5)




 

(d) Other dealings (including transactions in respect of new securities) (Note 4)

Nature of transaction
(Note 8)

Details

Price per unit
(if applicable) (Note 5)




                                           

4. OTHER INFORMATION
Agreements, arrangements or understandings relating to options or derivatives

Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated.


Is a Supplemental Form 8 attached? (Note 9) 

YES/NO?

Date of disclosure

27 March 2020

Contact name

Steven L. Scrogham

Telephone number

847-938-6166

Name of offeree/offeror with which acting in concert

AbbVie Inc.

Specify category and nature of acting in concert status

Director of AbbVie Inc.

 

SOURCE AbbVie


These press releases may also interest you

at 00:10
AgraFlora Organics International Inc.  ("AgraFlora" or the "Company") is pleased to announce its wholly owned subsidiary Sustainable Growth Strategic Capital Corp. ("SGSC" or "the Company"), a federally licensed cannabis company based in the...

at 00:00
Saina Health, in partnership with OmniHealth, is pleased to announce the launch of its brand new, powerful and interactive health management tool called InstaHealth - a new line of cloud-based services for easy and affordable EMR integration in...

at 00:00
Help.org, a trusted online resource for individuals who struggle with addiction and their loved ones, has announced the Best Rehab Facilities in Naples, Florida for 2020. The informational guide recognizes the top 3 rehab facilities based on cost,...

13 jui 2020
iProov today announces its partnership with Australian identity verification specialists IDV Pacific Pty Ltd. The announcement sees iProov expand its growing partner network and extend its services into Australia and New Zealand. IDV Pacific...

13 jui 2020
Arctic Vision, a clinical-stage biotechnology company incubated by Nan Fung Life Sciences and Pivotal BioVenture Partners China in 2019, today announced its $32mn Series A financing led by Morningside Ventures, together with its existing investors....

13 jui 2020
Revitope Oncology Inc ("Revitope Oncology")., a biotechnology company advancing a new class of precision cancer immunotherapies, its wholly-owned subsidiary Revitope Limited (Revitope Limited, together with Revitope Oncology, "Revitope") and Junshi...



News published on 30 march 2020 at 06:00 and distributed by: